ArticleMaterials today. Bio2026
Biomimetic double-layered electrospun nanofibrous scaffold with mussel adhesive protein coating and TGF-β3 encapsulation for enhanced tendon-bone healing in rotator cuff tears.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poor tendon-bone healing is a challenging issue and contributes to the high retear rate following rotator cuff tear (RCT) repair. The complex multiple tissue structure and limited chondrogenic capacity at the tendon-bone interface hinder effective regeneration and restoration of the enthesis. In this study, we developed a double-layered biomimetic nanofibrous scaffold encapsulating TGF-β3, further functionalized with a mussel adhesive protein (MAP) coating, to target the reconstruction of the torn rotator cuff's enthesis. The unique double-layer structure features distinct fibrous arrangements in each layer, mimicking the heterogeneous extracellular matrix structures of tendon and bone. This design provided a biomimetic environment conducive to the ingrowth of multiple tissues at the interface. In vitro studies demonstrated that the MAP-coated scaffold exhibited excellent biocompatibility and enhanced cell adhesion, facilitating tendon-bone interfacial integration. Moreover, the sustained release of TGF-β3 promoted stem cell recruitment and chondrogenic differentiation, as demonstrated both in vitro and in vivo. RNA-sequencing revealed that PI3K-Akt signaling pathway might be associated with the regulatory effects of the scaffold. In a rat RCT model, the composite scaffold significantly enhanced cartilage regeneration at the tendon-bone interface, restoring both enthesis structure and biomechanical properties. Therefore, the composite scaffold represents a promising strategy for improving tendon-bone healing and advancing interfacial tissue engineering in rotator cuff repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.